| The DNA methylation landscape of advanced prostate cancer SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ... Nature genetics 52 (8), 778-789, 2020 | 231 | 2020 |
| The immune landscape of prostate cancer and nomination of PD-L2 as a potential therapeutic target SG Zhao, J Lehrer, SL Chang, R Das, N Erho, Y Liu, M Sjöström, RB Den, ... JNCI: Journal of the National Cancer Institute 111 (3), 301-310, 2019 | 163 | 2019 |
| TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup DP Labbé, CJ Sweeney, M Brown, P Galbo, S Rosario, KM Wadosky, ... Clinical Cancer Research 23 (22), 7072-7083, 2017 | 112 | 2017 |
| Response to radiotherapy after breast-conserving surgery in different breast cancer subtypes in the swedish breast cancer group 91 radiotherapy randomized clinical trial M Sjöström, D Lundstedt, L Hartman, E Holmberg, F Killander, A Kovács, ... Journal of Clinical Oncology 35 (28), 3222-3229, 2017 | 100 | 2017 |
| Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer M Sjöström, L Hartman, D Grabau, T Fornander, P Malmström, ... Breast cancer research and treatment 145, 61-71, 2014 | 86 | 2014 |
| Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin CE Chu, M Sjöström, EA Egusa, EA Gibb, ML Badura, J Zhu, VS Koshkin, ... Clinical Cancer Research 27 (18), 5123-5130, 2021 | 84 | 2021 |
| Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer M Sjöström, SL Chang, N Fishbane, E Davicioni, SG Zhao, L Hartman, ... Journal of Clinical Oncology 37 (35), 3340, 2019 | 74 | 2019 |
| Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors M Sjöström, J Staaf, P Edén, F Wärnberg, J Bergh, P Malmström, M Fernö, ... Breast Cancer Research 20, 1-13, 2018 | 49 | 2018 |
| G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients S Broselid, B Cheng, M Sjöström, K Lövgren, HLP Klug-De Santiago, ... Clinical Cancer Research 19 (7), 1681-1692, 2013 | 49 | 2013 |
| Effect of radiotherapy after breast-conserving surgery depending on the presence of tumor-infiltrating lymphocytes: a long-term follow-up of the SweBCG91RT randomized trial A Kovács, A Stenmark Tullberg, E Werner Rönnerman, E Holmberg, ... Journal of Clinical Oncology 37 (14), 1179-1187, 2019 | 44 | 2019 |
| TROP2 expression across molecular subtypes of urothelial carcinoma and enfortumab vedotin-resistant cells J Chou, K Trepka, M Sjöström, EA Egusa, CE Chu, J Zhu, E Chan, ... European urology oncology 5 (6), 714-718, 2022 | 43 | 2022 |
| A combined shotgun and targeted mass spectrometry strategy for breast cancer biomarker discovery M Sjostrom, R Ossola, T Breslin, O Rinner, L Malmström, A Schmidt, ... Journal of proteome research 14 (7), 2807-2818, 2015 | 42 | 2015 |
| Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing MHE Tang, M Dahlgren, C Brueffer, T Tjitrowirjo, C Winter, Y Chen, ... Oncotarget 6 (35), 37169, 2015 | 31 | 2015 |
| Development and validation of a genomic profile for the omission of local adjuvant radiation in breast cancer M Sjöström, A Fyles, FF Liu, D McCready, W Shi, K Rey-McIntyre, ... Journal of Clinical Oncology 41 (8), 1533, 2023 | 28 | 2023 |
| Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer toward androgen independence S Linder, M Hoogstraat, S Stelloo, N Eickhoff, K Schuurman, H de Barros, ... Cancer discovery 12 (9), 2074-2097, 2022 | 25 | 2022 |
| An integrated functional and clinical genomics approach reveals genes driving aggressive metastatic prostate cancer R Das, M Sjöström, R Shrestha, C Yogodzinski, EA Egusa, LN Chesner, ... Nature Communications 12 (1), 4601, 2021 | 25 | 2021 |
| Prognosis associated with luminal and basal subtypes of metastatic prostate cancer R Aggarwal, NR Rydzewski, L Zhang, A Foye, W Kim, KT Helzer, ... JAMA oncology 7 (11), 1644-1652, 2021 | 23 | 2021 |
| Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent M Sjöström, L Hartman, G Honeth, D Grabau, P Malmström, C Hegardt, ... Journal of Clinical Pathology 68 (12), 1012-1019, 2015 | 23 | 2015 |
| The 5-hydroxymethylcytosine landscape of prostate cancer M Sjöström, SG Zhao, S Levy, M Zhang, Y Ning, R Shrestha, A Lundberg, ... Cancer research 82 (21), 3888-3902, 2022 | 22 | 2022 |
| Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up J Tutzauer, M Sjöström, E Holmberg, P Karlsson, F Killander, ... British journal of cancer 126 (8), 1145-1156, 2022 | 22 | 2022 |
